ALNY

NASDAQStock

Alnylam Pharmaceuticals, Inc.

$313.45-3.77 (-1.19%)

52-Week Range

$224.32
$491.22

Key Stats

Market Cap

41.6B

P/E Ratio

155.95

Dividend Yield

Beta

0.38

Volume

526.0K

Avg Volume

1.5M

Performance

1M

+2.84%

3M

-18.97%

6M

-31.21%

YTD

-20.73%

1Y

+31.22%

3Y

+70.78%

5Y

+117.10%

Price Chart

ETF Exposure

ALNY is held by 460 ETFs

ETFFund NameWeight
GERMETFMG Treatments, Testing and Advancements ETF11.39%
MNTLTema Neuroscience And Mental Health ETF7.74%
MSGRDirexion mRNA ETF6.45%
PBEInvesco Biotechnology & Genome ETF5.09%
MEDXHorizon Kinetics Medical ETF3.96%
IBBiShares Biotechnology ETF3.65%
QQQNVictoryShares Nasdaq Next 50 ETF3.64%
BBHVanEck Biotech ETF3.51%
SBIO.LInvesco NASDAQ Biotech UCITS ETF3.24%
IBBQInvesco Nasdaq Biotechnology ETF3.24%
DBX4.DEXtrackers MSCI EM Europe, Middle East & Africa ESG Swap UCITS ETF3.10%
XMXD.LXtrackers MSCI EM Europe, Middle East & Africa ESG Swap UCITS ETF 1C3.10%
FBTFirst Trust NYSE Arca Biotechnology Index Fund2.88%
TYNEDirexion Nanotechnology ETF2.84%
FMEDFIDELITY DISRUPTIVE MEDICINE ETF2.82%
GNOG.LGlobal X - Genomics & Biotechnology UCITS ETF2.72%
GNOM.LGlobal X - Genomics & Biotechnology UCITS ETF2.72%
GNOMGlobal X - Genomics & Biotechnology ETF2.53%
HELXFranklin Genomic Advancements ETF2.50%
FDGAmerican Century Focused Dynamic Growth ETF2.46%
BIBProShares - Ultra Nasdaq Biotechnology2.32%
ROCIROC ETF1.94%
XMAF.LXtrackers MSCI Africa Top 50 Swap UCITS ETF 1C1.93%
XMKA.DEXtrackers MSCI Africa Top 50 Swap UCITS ETF 1C1.93%
PFUTPutnam Sustainable Future ETF1.86%
QQEWFirst Trust Nasdaq-100 Select Equal Weight ETF1.76%
HTECROBO Global Healthcare Technology and Innovation ETF1.53%
JMIDJanus Henderson Mid Cap Growth Alpha ETF1.52%
BMEDiShares Health Innovation Active ETF1.47%
CAMLCongress Large Cap Growth ETF1.42%
QQXTFirst Trust NASDAQ-100 Ex-Technology Sector Index Fund1.42%
IWPiShares Russell Mid-Cap Growth ETF1.41%
MIDAmerican Century Mid Cap Growth Impact ETF1.32%
BBPVirtus Biotech ETF1.27%
HRTSTema Cardiovascular and Metabolic ETF1.20%
VOTVanguard Mid-Cap Growth ETF1.18%
NWLGNuveen Winslow Large-Cap Growth ESG1.16%
DRUPGraniteShares Nasdaq Select Disruptors ETF1.15%
MRNDIQ U.S. Mid Cap R&D Leaders ETF1.14%
FXHFirst Trust Health Care AlphaDEX Fund1.11%
PBPHPortfolio Building Block World Pharma and Biotech Index ETF1.10%
MEDIHarbor Health Care ETF (MEDI)1.10%
NXTISimplify NEXT Intangible Core Index ETF1.07%
CURE.AXGlobal X - S&P Biotech ETF1.00%
XBIState Street SPDR S&P Biotech ETF1.00%
QNXTiShares Nasdaq-100 ex Top 30 ETF0.98%
CGGRCapital Group Growth ETF0.89%
MXDUNationwide Maximum Diversification U.S. Core Equity ETF0.83%
QQQEDirexion NASDAQ-100 Equal Weighted Index ETF0.82%
FMDEFIDELITY ENHANCED MID CAP ETF0.80%
Page 1 of 10Next

About ALNY ETF Exposure

Alnylam Pharmaceuticals, Inc. (ALNY) is held by 460 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 41.6B, ALNY is a widely held institutional stock. The stock currently trades at $313.45. Investors can gain exposure to ALNY through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ALNY, sorted by portfolio weight.